Telangana – 29th state of India

Telangana becomes a reality as the 29th state of India, capping the decades-old struggle in the region for carving out a separate state from Andhra Pradesh. President’s rule imposed in united Andhra Pradesh would be revoked partially to facilitate the swearing-in of TRS government in the newly-created Telangana headed by K Chandrasekhar Rao. Governor ESL … Read more

HIV :: HIV-TB spreads in Africa, undermines control of world’s 2 deadliest infectious diseases

The largely unnoticed collision of the global epidemics of HIV and tuberculosis (TB) has exploded to create a deadly co-epidemic that is rapidly spreading in sub-Saharan Africa. However, health systems cannot adequately diagnose, treat, or contain the co-epidemic due to unanswered scientific and medical questions, according to a report issued today by The Forum for Collaborative HIV Research and amplified by experts from leading global health organizations.

HIV :: AHF Welcomes FDA Approval of Pfizer?s Selzentry AIDS Drug

On the heels of the fourth International AIDS Society?s Conference on HIV Pathogenesis, Treatment and Prevention, which took place in Sydney in late July, AIDS Healthcare Foundation (AHF) welcomed yesterday?s news that the FDA has approved Pfizer Inc.?s new AIDS salvage therapy, Selzentry (maraviroc), a different class of new antiretroviral AIDS drug which had been discussed and presented at the IAS conference.

HIV :: New publication presents latest in HIV/TB treatment, research

With HIV infection driving a deadly resurgence of tuberculosis (TB), a new publication provides up-to-date recommendations for clinicians facing the many challenges of treating patients with both of these two complex diseases.

HIV :: TMC125 demonstrates efficacy in patients with NNRTI resistance in phase III trials

TMC125 (etravirine, ETR), Tibotec’s investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), demonstrated significant efficacy in patients with NNRTI resistance, according to the 24-week primary endpoint analysis from two ongoing, phase III studies published in the 7 July, 2007, issue of The Lancet.

Do NOT follow this link or you will be banned from the site!